{
  "ticker": "EW",
  "last_updated": "2026-02-24T09:02:10.033552",
  "retention_years": 3,
  "count": 4,
  "transactions": [
    {
      "id": 1737,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2026-02-22",
      "transaction_shares": "432.0000",
      "transaction_price": "79.7800",
      "transaction_type": "F",
      "shares_after_transaction": "33933.9103"
    },
    {
      "id": 1740,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Dahl Andrew M.",
      "reporting_owner_cik": "0002022347",
      "reporting_owner_position": "SVP, Corporate Controller",
      "transaction_date": "2026-02-22",
      "transaction_shares": "176.0000",
      "transaction_price": "79.7800",
      "transaction_type": "F",
      "shares_after_transaction": "9089.4805"
    },
    {
      "id": 1738,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2026-02-16",
      "transaction_shares": "199.0000",
      "transaction_price": "75.8700",
      "transaction_type": "F",
      "shares_after_transaction": "39699.0000"
    },
    {
      "id": 1739,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lippis Daniel J.",
      "reporting_owner_cik": "0002004380",
      "reporting_owner_position": "CVP, TAVR",
      "transaction_date": "2026-02-12",
      "transaction_shares": "12820.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "34821.9103"
    }
  ]
}